Eupraxia Pharmaceuticals Inc. EPRX
8.01
(0.15)
(1.84%)
as of 25 Sep
- Market cap
- $537.8M
- P/E
- 0.0×
Follow EPRX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
15.12 | 11.10 | 1.02 | 6.08 |
Net Debt/EBITDA |
2.11 | 1.23 | 0.32 | 0.53 |
Debt/Assets |
0.09% | 0.00% | 51.31% | 46.73% |
Debt/Equity |
0.00 | 0.00 | 11.65 | 1.24 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.69 | 1.16 | 0.74 | 0.78 |
Capex/Depreciation |
(2.48) | (0.44) | (0.47) | (1.59) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (161.71%) | (5,054.21%) | (696.79%) | 0.00% | |
| (67.89%) | (93.93%) | (143.29%) | 0.00% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(51.19%) | (81.81%) | (3,364.43%) | (115.75%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.73) | (0.89) | (0.86) | (0.76) |
Cash per Share |
2.02 | 0.98 | 0.80 | 0.95 |
Shareholders Equity per Share |
2.01 | 0.94 | 0.04 | 0.37 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.01 | 0.94 | 0.04 | 0.37 |
Free Cash Flow |
(29.14) | (30.07) | (20.82) | (14.63) |
Working Capital |
79.47 | 31.33 | 0.43 | 15.53 |
Capital Expenditures |
(0.59) | (0.08) | (0.07) | (0.24) |
Net Current Asset Value |
79.39 | 31.33 | 0.43 | 6.67 |
| Other line items | ||||
Quick Ratio |
14.43 | 10.74 | 1.01 | 6.00 |
Depreciation/Fixed assets |
0.28 | 0.48 | 0.38 | 0.33 |
Cash ROIC |
(18.24%) | (46.74%) | (69.07%) | (43.13%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.71) | (0.88) | (0.86) | (0.75) |
Capex per Share |
(0.01) | 0.00 | 0.00 | (0.01) |
Average Receivables |
0.45 | 0.21 | 0.14 | — |
Average Payables |
4.29 | 3.48 | 3.43 | — |
Average Assets |
60.55 | 27.60 | 19.69 | — |
Average Common Equity |
25.42 | 0.51 | 4.05 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates